TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SIMCELL

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

SIMCELL

ST13

US500000079340855

Classe

1, 5, 42, 44

Pedido

79340855

Registro

7272903

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

07/05/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 44

Data de depósito

12/01/2022

Data de registro

16/01/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/01/2024

Última transação

16/01/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

O'BRIEN, JENNIFER

Unidade examinadora

N30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Oxford Simcell Limited

Representantes

Scott J. Major Millen White Zelano & Branigan, PC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Biological preparations for use in industry and science; cells for research and scientific purposes; cell culture reagents for scientific and research use; bacterial preparations, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use in the nature of biological preparations for use in industry and science; biological preparation for use in cell cultures, other than for medical or veterinary use; biological tissue cultures, other than for medical and veterinary use

Classe 5

Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical and medical preparations for the treatment and prevention of infectious diseases, cancers, metabolic diseases, and neurological diseases; cells for medical and veterinary use; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; biological preparations for medical and veterinary use for the treatment and prevention of infectious diseases, cancers, metabolic diseases, and neurological diseases; biological tissue cultures for medical and veterinary use; biological tissue cultures of microorganisms for medical and veterinary use; diagnostic preparations and materials, namely diagnostic reagents for veterinary, medical and clinical medical use, diagnostic substances for medical purposes, diagnostic preparations for pharmaceutical use, diagnostic biomarker reagents for medical and veterinary purposes, diagnostic reagents for medical and veterinary use in in vivo and in vitro diagnosis, and diagnostic reagents for veterinary, medical and clinical medical use in the nature of biological markers for therapeutic or diagnostic use; diagnostic preparations for medical and veterinary purposes; in vitro diagnostic preparations for medical use

Classe 42

Scientific and technological services, namely, scientific research, analysis, testing, scientific research advisory, technological advisory, advisory on scientific and technological research in the field of manufacturing processes and consultancy services in the field of microorganisms and cells, and bacterial therapy, and research and design relating thereto; scientific research; scientific analysis in the field of microorganisms and cells, and bacterial therapy; technical data analysis services, namely, technical research in the field of microorganisms and cells, and bacterial therapy; research and development in the field of microorganisms and cells; biological research; bacteriological research; scientific services in the nature of cell culture services for scientific and research purposes, for others relating to the isolation and cultivation of human cells; cell culture services for scientific and research purposes for others; cell culture services for scientific and research purposes for others, namely, cell separation research and cell separation technology research services; research and development in the field of bacterial therapy; design and development of medical diagnostic testing apparatus and reagents; scientific laboratory testing services; information, advice and consultancy services relating to the aforementioned

Classe 44

Medical services; veterinary services; medical treatment services, namely, care for patients with, and prevention of, diseases using non-replicating cells; medical services relating to the treatment and processing of human cells; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical therapy services, namely, nutritional therapy services, stem cell therapy services, bacterial therapy services, intravenous therapy services, hormone therapy services, immunotherapy services, therapy for disease prevention and vaccine therapy services; medical analysis services relating to the treatment of persons, namely, analysis of human tissues for the purposes of medical care and disease prevention; diagnostic testing services, namely, medical, genetic and veterinary testing, for diagnostic or medical treatment purposes; diagnostic testing relating to human health, namely, medical and genetic testing for diagnostic or medical treatment purposes; information, advice and consultancy services relating to the aforementioned

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/05/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

17/04/2024

FIMP

FINAL DISPOSITION PROCESSED

17/04/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

16/04/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

22/01/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

16/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

16/01/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/11/2023

GPNX

NOTIFICATION PROCESSED BY IB

31/10/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

31/10/2023

PUBO

PUBLISHED FOR OPPOSITION

31/10/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/10/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

25/10/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/10/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

28/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/09/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/09/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/08/2023

GNFR

FINAL REFUSAL E-MAILED

07/08/2023

CNFR

FINAL REFUSAL WRITTEN

07/08/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/06/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/06/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/06/2023

RFNT

REFUSAL PROCESSED BY IB

15/01/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

27/12/2022

RFRR

REFUSAL PROCESSED BY MPU

27/12/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

30/10/2022

CNRT

NON-FINAL ACTION WRITTEN

29/10/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

24/10/2022

DOCK

ASSIGNED TO EXAMINER

20/10/2022

MAFR

APPLICATION FILING RECEIPT MAILED

24/05/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/05/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

19/05/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SIMCELL ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.